LabcorpLHEarnings & Financial Report
Lab most often refers to:Laboratory, a facility to conduct scientific research and experiments.
LH Q3 2025 Key Financial Metrics
売上高
$3.6B
粗利益
$1.0B
営業利益
$396.6M
純利益
$261.1M
粗利益率
28.8%
営業利益率
11.1%
純利益率
7.3%
前年比成長
8.6%
EPS
$3.12
資金フロー
Labcorp Q3 2025 Financial Summary
Labcorp reported revenue of $3.6B for Q3 2025, with a net profit of $261.1M (7.3% margin). Cost of goods sold was $2.5B, operating expenses totaled $628.5M.
Key Financial Metrics
| Total Revenue | $3.6B |
|---|---|
| Net Profit | $261.1M |
| Gross Margin | 28.8% |
| Operating Margin | 11.1% |
| Report Period | Q3 2025 |
Labcorp Annual Revenue by Year
Labcorp annual revenue history includes year-by-year totals (for example, 2024 revenue was $13.0B).
| Year | Annual Revenue |
|---|---|
| 2024 | $13.0B |
| 2023 | $12.2B |
| 2022 | $14.9B |
損益計算書
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $2.29B | $3.18B | $3.22B | $3.28B | $3.33B | $3.35B | $3.53B | $3.56B |
| 前年比成長 | -37.6% | -15.9% | 6.2% | 7.4% | 45.2% | 5.3% | 9.5% | 8.6% |
貸借対照表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $16.73B | $16.53B | $16.71B | $18.61B | $18.38B | $17.60B | $18.06B | $18.26B |
| 総負債 | $8.83B | $8.56B | $8.69B | $10.43B | $10.31B | $9.28B | $9.57B | $9.55B |
| 株主資本 | $7.88B | $7.96B | $8.01B | $8.17B | $8.05B | $8.31B | $8.47B | $8.70B |
キャッシュフロー
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 営業CF | $579.6M | $-29.8M | $561.1M | $277.3M | $777.2M | $18.5M | $620.6M | $387.2M |
Other Health Care Companies
CI
Cigna
売上高
$69.7B
純利益
N/A
CVS
CVS Health
売上高
$105.7B
純利益
$2.9B
DVA
DaVita
売上高
$3.6B
純利益
$234.2M
DGX
Quest Diagnostics
売上高
$2.8B
純利益
$245.0M
ABT
Abbott Laboratories
売上高
$11.4B
純利益
$1.6B
ABBV
AbbVie
売上高
$15.8B
純利益
$186.0M
A
Agilent Technologies
売上高
$1.9B
純利益
$434.0M
ALGN
Align Technology
売上高
$995.7M
純利益
$56.8M
AMGN
Amgen
売上高
$9.9B
純利益
$1.3B
BAX
Baxter International
売上高
$3.0B
純利益
$-1.1B